Innoviva: The Royalty Decline Is Real, But The Valuation Is Too Pessimistic (NASDAQ:INVA)

seekingalpha.com · 2026-08-06

Innoviva's strategic investments valued at $773 million carry a meaningful impairment risk while providing upside optionality. Learn more about INVA stock here.

Read the full story at seekingalpha.com →